12936_2016_1466_MOESM3_ESM.docx (12 kB)
MOESM3 of Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara
journal contribution
posted on 2016-08-30, 05:00 authored by Mahamadou Thera, Drissa Coulibaly, Abdoulaye Kone, Ando Guindo, Karim Traore, Abdourhamane Sall, Issa Diarra, Modibo Daou, Idrissa Traore, Youssouf Tolo, Mady Sissoko, Amadou Niangaly, Charles Arama, Mounirou Baby, Bourema Kouriba, Mahamadou Sissoko, Issaka Sagara, Ousmane Toure, Amagana Dolo, Dapa Diallo, Edmond Remarque, Roma Chilengi, Ramadhani Noor, Sanie Sesay, Alan Thomas, Clemens Kocken, Bart Faber, Egeruan Imoukhuede, Odile Leroy, Ogobara DoumboAdditional file 3. Abnormal laboratory parameters grading intensity.